Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Caixa Capital Risc

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 159
Average round size
The average size of a deal this fund participated in
Portfolio companies 120
Rounds per year 7.95
Lead investments 47
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 18
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Software
  • E-Commerce
  • Mobile
  • Information Technology

In 2004 was created Caixa Capital Risc, which is appeared as VC. The fund was located in Europe if to be more exact in Spain. The main department of described VC is located in the Barcelona.

The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Health Care, SaaS. Among the most popular portfolio startups of the fund, we may highlight CornerJob, Minoryx Therapeutics, Groupalia. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The overall number of key employees were 3.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Caixa Capital Risc, startups are often financed by Wayra, Ysios Capital, Cabiedes & Partners. The meaningful sponsors for the fund in investment in the same round are Bonsai Venture Capital SCR, Cabiedes & Partners, Xesgalicia. In the next rounds fund is usually obtained by Ysios Capital, Idinvest Partners, Sweet Capital.

Comparing to the other companies, this Caixa Capital Risc performs on 19 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2018. The average startup value when the investment from Caixa Capital Risc is 10-50 millions dollars. The fund is constantly included in 7-12 deals per year. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Caixa Capital Risc:
Typical Co-investors
Caixa Capital Risc is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Caixa Capital Risc:

Funds with similar focus

Funds from Spain
Funds with similar focus located in Spain:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Augmented Reality
Industrial Manufacturing
Information Technology
$2M22 Jun 2022 London, England, United Kingdom

Minoryx Therapeutics

$60M31 May 2022 Barcelona, Catalonia, Spain

Barbara IoT

Cyber Security
Embedded Software
Internet of Things
Operating Systems
$3M11 May 2022 Madrid, Madrid, Spain

Knowledge Development for Rugged Optical Communications

14 Dec 2021 -

Aelix Therapeutics

Health Care
$2M16 Sep 2021 Barcelona, Catalonia, Spain


Health Care
Information Technology
Medical Device
$21M10 Feb 2021 Spain, Community of Madrid


Artificial Intelligence
Cyber Security
Information Technology
Mobile Apps
Mobile Payments
$3M19 Jan 2021 Munich, Bavaria, Germany

MealFood Europe

Food and Beverage
Health Care
01 Jun 2020 Spain, Castile and León


Artificial Intelligence
Big Data
Developer Tools
$2M27 Feb 2020 A Coruña, Galicia, Spain
MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

– MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round.
– MedLumics’ optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
– This round was led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II.
– MedLumics is now ready to initiate first in-human regulatory clinical studies and automate scalable product manufacturing.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Caixa Capital Risc?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: